US-based CBD producer Folium Biosciences is looking to tap Asian markets by creating a dedicated stalk extraction line which it believes will meet the strict regulatory requirements of Japan and South Korea
Written by CannIntelligence || 29th September 2020 || News analysis | Companies | Technology and innovation | Asia Japan North America South Korea United States